Vosoritide approved for treatment of linear growth in pediatric patients with achondroplasia: A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG)

Genet Med Open. 2023 Mar 27;1(1):100771. doi: 10.1016/j.gimo.2023.100771. eCollection 2023.
No abstract available

Keywords: Achondroplasia; Linear growth; Pediatrics; Vosoritide.